Tranzactioneaza Ardelyx (US.ARDX) - 6.09 USD (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 6.080 USD
Ask 6.100 USD
Minim 5.920 USD
Maxim 6.400 USD
Pret referinta 5.870
Volum -
Volum ultima zi 1
Max 52 sapt 10.130 USD
Min 52 sapt 3.440 USD

Descriere companie

Ardelyx, Inc. (www.ardelyx.com) is a biopharmaceutical company focused on the discovery, development, and commercialization of medicines to improve treatment for people with kidney and cardiorenal diseases. The Company's product pipeline includes Tenapanor, IBSRELA, RDX013 Program, and RDX020 Program. The Tenapanor is a medicine for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Tenapanor for the control of serum phosphorus has a mechanism of action and acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3). IBSRELA is developed for the treatment of patients with irritable bowel syndrome with constipation (IBS-C). RDX013 Program is a small molecule potassium secretagogue program for the potential treatment of hyperkalemia. RDX020 Program is a small molecule for treating metabolic acidosis. It has a discovery program targeting the inhibition of intestinal bicarbonate exchange for the treatment of metabolic acidosis.

Informatii companie

Nume

Ardelyx, Inc.